

House
File
2501
-
Introduced


HOUSE
FILE
2501


BY
COMMITTEE
ON
JUDICIARY


(SUCCESSOR
TO
HSB
600)


A
BILL
FOR


An
Act
relating
to
civil
actions
involving
asbestos
and
silica,
1


and
including
applicability
provisions.
2


BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
3


TLSB
5524HV
(4)
88


ko/jh



H.F.
2501


Section
1.
Section
686B.3,
subsection
2,
Code
2020,
is
1


amended
to
read
as
follows:
2


2.
A
plaintiff
in
an
asbestos
action,
including
an
action


3


alleging
a
nonmalignant
or
a
malignant
condition,
or
a
silica
4


action
involving
silicosis,


shall
include
with
the
detailed
5


narrative
medical
report


file
with
the
petition
or
other
6


initial
pleading
a
sworn
information
form
containing
specifying
7


the
evidence
that
provides
the
basis
for
each
claim
against
8


each
defendant.
The
sworn
information
form
shall
include


all
9


of
the
following
with
specificity
:
10


a.
The
name,
address,
date
of
birth,
social
security
number,


11


marital
status,
occupation,
current
and
past
worksites,
and
12


employer
of
the
exposed
person
,
and
any
person
through
whom
the
13


exposed
person
alleges
exposure


.
14


b.
The
plaintiff’s
relationship
to
the
exposed
person
or
15


person
through
whom
the
exposure
is
alleged.
16


b.
Each
person
through
whom
the
exposed
person
was
exposed
17


to
asbestos
or
silica,
and
the
exposed
person’s
relationship


18


to
each
person.


19


c.
Each
asbestos-containing
product
or
silica
product,
20


whether
from
a
bankrupt
entity
or
otherwise,
to
which
the


21


exposed
person
was
exposed,
or
if
the
exposed
person
was
22


exposed
through
another
person,
to
which
that
person
was


23


exposed.
24


c.
d.
The
specific
location
and
manner
of
each
alleged
25


exposure,
including
the
specific
location
and
manner
of
26


exposure
for
any
person
through
whom
the
exposed
person
alleges
27


exposure
was
exposed
to
asbestos
or
silica
.
28


d.
e.
The
beginning
and
ending
dates
of
each
alleged
29


exposure
and
the
frequency
of
the
exposure
of
the
exposed


30


person
to
the
product
or
its
use,
including
for
any
person
31


through
whom
the
exposed
person
was
exposed


.
32


e.
f.
The
identity
of
the
manufacturer
or
seller
of
the
33


specific
asbestos
or
silica
product
for
each
exposure.
34


f.


The
identity
of
the
defendant
or
defendants
against
whom
35


-1-


LSB
5524HV
(4)
88


ko/jh


1/
3





















































H.F.
2501


the
plaintiff
asserts
a
claim.
1


g.
The
specific
asbestos-related
or
silica-related
disease
2


claimed
to
exist.
3


h.
Any
supporting
documentation
relating
to
the
information
4


required
under
this
subsection.
5


Sec.
2.
Section
686B.3,
subsection
3,
Code
2020,
is
amended
6


by
striking
the
subsection.
7


Sec.
3.
Section
686B.3,
subsection
5,
Code
2020,
is
amended
8


to
read
as
follows:
9


5.
The
court
shall
dismiss
the
asbestos
action
or
silica
10


action
without
prejudice
on
finding
that
the
plaintiff
has
11


failed
to
make
the
prima
facie
showing
required
by
this
chapter
12


or
failed
to
comply
with
the
requirements
of
this
section


13


subsections
1
and
2


.
The
court
shall
dismiss
the
asbestos
14


action
or
silica
action
without
prejudice
as
to
any
defendant
15


whose
product
or
premises
is
not
identified
in
the
information
16


required
pursuant
to
subsection
2.
17


Sec.
4.
APPLICABILITY.
This
Act
applies
to
an
asbestos
18


action,
including
an
action
alleging
a
nonmalignant
or
19


malignant
condition,
or
a
silica
action
involving
silicosis
20


filed
on
or
after
July
1,
2020.
21


EXPLANATION
22


The
inclusion
of
this
explanation
does
not
constitute
agreement
with
23


the
explanation’s
substance
by
the
members
of
the
general
assembly.
24


This
bill
relates
to
civil
actions
involving
asbestos
and
25


silica.
26


The
bill
requires
a
plaintiff
in
an
asbestos
action,
27


including
an
action
alleging
a
nonmalignant
or
a
malignant
28


condition,
or
a
silica
action
involving
silicosis,
to
file
with
29


the
petition
or
other
initial
pleading
a
sworn
information
30


form
specifying
the
evidence
that
provides
the
basis
for
each
31


claim
against
each
defendant.
The
sworn
information
form
must
32


contain
the
information
as
detailed
in
the
bill.
Current
law
33


does
not
require
a
plaintiff
in
an
asbestos
action,
including
34


an
action
alleging
a
malignant
condition,
or
a
silica
action
35


-2-


LSB
5524HV
(4)
88


ko/jh


2/
3










H.F.
2501


involving
silicosis,
to
file
a
sworn
information
form
stating
1


the
basis
for
each
claim
against
each
defendant.
2


The
bill
directs
the
court
to
dismiss
an
asbestos
action
or
3


a
silica
action
without
prejudice
on
finding
that
a
plaintiff
4


has
failed
to
make
a
prima
facie
case.
The
court
is
also
5


required
to
dismiss
an
asbestos
action
or
silica
action
without
6


prejudice
as
to
each
defendant
whose
product
or
premises
is
7


not
identified
in
the
sworn
information.
The
court
shall
also
8


dismiss
the
action
without
prejudice
as
to
all
defendants
if
9


the
plaintiff
fails
to
comply
with
the
requirements
for
the
10


sworn
statement
or
the
requirement
that
the
plaintiff
file
a
11


detailed
medical
report.
12


The
provisions
in
the
bill
apply
to
asbestos
actions,
13


including
actions
alleging
a
nonmalignant
or
malignant
14


condition,
or
silica
actions
involving
silicosis
filed
on
or
15


after
July
1,
2020.
16


-3-


LSB
5524HV
(4)
88


ko/jh


3/
3

